| Members |
targetComponentId |
| Sucralfate 1mg tablet |
Product containing precisely sucralfate 1 gram/1 each conventional release oral tablet (clinical drug) |
| sackaros 30 %, ögondroppar |
Product containing precisely sucrose 300 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Sue Spences bedömning |
Spence Children's Anxiety Scale |
| sufentanilcitrat 50 mikrogram/ml, injektionsvätska, lösning, ampull |
Sufentanil only product |
| Suffocation by constriction |
Asphyxiation by sustained compression of chest |
| Sulfabenzamide + sulfacetamide + sulfathiazole 3.7%ww/2.86%ww/3.42%ww cream |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream |
| sulfabensamid 3,7 % + sulfacetamid 2,86 % + sulfatiazol 3,42 %, vaginalkräm |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream |
| sulfacetamid 10 %, ögonsalva |
Sulfacetamide sodium 100 mg/g eye ointment |
| sulfacetamid 10 %, lösning |
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
| sulfacetamid 2,5 %, ögonsalva |
Sulfacetamide sodium 25 mg/g eye ointment |
| sulfacetamid 20 %, ögondroppar |
Sulfacetamide sodium 200 mg/mL eye solution |
| sulfacetamid 30 %, ögondroppar |
Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug) |
| sulfacetamid 6 %, ögonsalva |
Sulfacetamide sodium 60 mg/g eye ointment |
| sulfacetamidnatrium 10 %, ögondroppar |
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Sulfacetamide sodium 10% ointment |
Sulfacetamide sodium 100 mg/g eye ointment |
| sulfadiazin 1 g/4 ml, för injektion |
Sulfadiazine 250 mg/mL solution for injection |
| Sulfamethoxpyridazine |
Sulfamethoxypyridazine (substance) |
| sulfasalazin 3 g/100 ml, retentionslavemang |
Sulfasalazine 30 mg/mL rectal suspension |
| Sulfisoxazole 500mg/5 ml suspension |
Sulfafurazole 100 mg/mL oral suspension |
| Sulfisoxazole acetyl 0.5g/5mL suspension |
Sulfafurazole 100 mg/mL oral suspension |
| sulfafurazolacetyl 500 mg/5 ml, suspension |
Sulfafurazole 100 mg/mL oral suspension |
| överdos av sulfonamid |
Sulfonamide antibacterial overdose |
| Sulfotransferase |
Sulfotransferase |
| svavelhexafluorid 40 mikroliter, pulver till injektionsvätska, lösning |
Product containing only sulfur hexafluoride (medicinal product) |
| svavelhexafluorid 40 mikroliter, pulver till injektionsvätska + lösningsmedel |
Product containing only sulfur hexafluoride (medicinal product) |
| Sulfuric ester hydrolase |
Sulfatase |
| Sulfurtransferase |
Sulfurtransferase |
| Sulphacetamide 30% eye drops |
Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Sulphur hexafluoride 40microlitres injection (pdr for recon)+solvent |
Product containing only sulfur hexafluoride (medicinal product) |
| sumatriptan 10 mg, nässprej |
Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug) |
| sumatriptan 12 mg/ml, injektionsvätska, lösning, förfylld spruta 0,5 ml |
Sumatriptan succinate 12 mg/mL solution for injection |
| sumatriptan 20 mg, nässprej |
Product containing precisely sumatriptan 20 milligram/1 actuation conventional release nasal spray (clinical drug) |
| sumatriptan 4 mg, injektionsvätska, lösning, förfylld cylinderampull |
Product containing only sumatriptan in parenteral dose form (medicinal product form) |
| sumatriptan 5 mg, nässprej |
Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
| sumatriptan 6 mg, injektionsvätska, lösning, förfylld cylinderampull |
Product containing only sumatriptan in parenteral dose form (medicinal product form) |
| Sumatriptan 6mg/0.5mL injection |
Sumatriptan succinate 12 mg/mL solution for injection |
| Sumatriptan 6mg/0.5mL injection refill |
Sumatriptan succinate 12 mg/mL solution for injection |
| Sumatriptan succinate 12mg/mL injection solution 0.5mL prefilled syringe |
Sumatriptan succinate 12 mg/mL solution for injection |
| Sumatriptan succinate 6mg injection solution 0.5mL prefilled syringe |
Sumatriptan succinate 12 mg/mL solution for injection |
| Sumatriptan succinate 6mg/0.5mL injection |
Sumatriptan succinate 12 mg/mL solution for injection |
| Superfamily Syngamoidea |
Family Syngamidae (organism) |
| Superfamily scolioidea |
Superfamily Vespoidea (organism) |
| Superfamily vespoidea |
Family Vespidae (organism) |
| Superficial partial thickness burn of hand, unspecified |
Burn of hand |
| Superficial pressure sore |
Pressure injury stage I (disorder) |
| ytligt trycksår |
Pressure injury stage I (disorder) |
| Superior oblique muscle innervation disorder |
Fourth nerve palsy |
| Superorder Marsupalia |
Infraclass Metatheria (organism) |
| chef för maskinskriverskor etc. |
Secretarial supervisor |
| Surgical construction of fistula |
Construction of shunt |
| resektionsgränser |
Surgical margin (morphologic abnormality) |
| Surgical repair - action |
Repair - action |
| Surgical repair of small bowel |
Operative procedure on small intestine |
| nekros i operationssår |
Surgical wound necrosis (finding) |
| misstänkt cystisk fibros hos fostret |
Suspected cystic fibrosis in fetus (situation) |
| misstänkt anencefali hos fostret |
Suspected foetal anencephaly |
| misstänkt skada på foster på grund av alkohol via modern |
Suspected fetal damage from maternal alcohol (situation) |
| misstänkt skada på foster på grund av toxoplasmos hos modern |
Suspected foetal damage from maternal toxoplasmosis |
| Suspect mongol fetus |
Suspect trisomy 21 fetus |
| misstänkt trångvinkelglaukom |
Angle closure glaucoma suspect (disorder) |
| misstänkt skada på foster på grund av sjukdom hos modern |
Suspected foetal damage from disease in the mother |
| Suspected damage to fetus from disease in the mother, NEC |
Suspected foetal damage from disease in the mother |
| misstänkt skada på foster på grund av toxin i den yttre miljön |
Suspected fetal damage from environmental toxin (situation) |
| misstänkt skada på foster på grund av intrauterint preventivmedel |
Suspected foetal damage from intrauterine contraceptive device |
| misstänkt skada på foster på grund av alkoholmissbruk hos modern |
Suspected foetal damage from maternal alcohol addiction |
| misstänkt skada på foster på grund av moderns användning av läkemedel |
Suspected foetal damage from maternal drug use |
| misstänkt skada på foster på grund av listerios hos modern |
Suspected fetal damage from maternal listeriosis (situation) |
| misstänkt skada på foster på grund av röda hund hos modern |
Fetus with suspected rubella damage via mother |
| misstänkt skada på foster på grund av toxoplasmos hos modern |
Suspected foetal damage from maternal toxoplasmosis |
| misstänkt skada på foster på grund av strålning |
Suspected fetal damage from radiation |
| misstänkt skada på foster på grund av virussjukdom hos modern |
Suspected fetal damage from viral disease in mother (situation) |
| misstänkt glaukom i samband med diabetes mellitus typ 2 |
Glaucoma suspect due to diabetes mellitus type 2 (disorder) |
| misstänkt glaukom i båda ögonen orsakat av steroider |
Glaucoma suspect of bilateral eyes caused by corticosteroid (disorder) |
| misstänkt glaukom i vänster öga orsakat av steroider |
Glaucoma suspect of left eye caused by corticosteroid |
| misstänkt glaukom i höger öga orsakat av steroider |
Glaucoma suspect of right eye caused by corticosteroid (disorder) |
| inflammerad suturlinje |
Suture line inflamed (finding) |
| Suture of spermatic cord |
Repair of spermatic cord |
| sötpotatis, livsmedel |
Sweet potato (substance) |
| Swine vesicular disease virus |
Human coxsackievirus B5 |
| svullna fötter |
Swelling of bilateral feet (finding) |
| svullna ben |
Swelling of bilateral lower limbs (finding) |
| Symphalangy |
Syndactyly (disorder) |
| syncefalus |
Syncephalus |
| Syncytial endometritis |
Exaggerated placental site (morphologic abnormality) |
| Syngamus laryngeus |
Mammomonogamus laryngeus |
| synovialt sarkom, kategori |
Synovial sarcoma |
| Syntactical aphasia |
Syntactical aphasia (finding) |
| Synthetic patch repair |
Repair - action |
| Syphilitic gumma of other sites |
Syphilitic gumma |
| Syringing - action |
Irrigation - action (qualifier value) |
| Systemic chondromalacia |
Relapsing polychondritis |
| Other acquired deformity of finger, NEC |
Deformity of phalanx of finger or thumb |
| systemiskt inflammatoriskt svarssyndrom i samband med organsvikt |
Acute organ dysfunction due to systemic inflammatory response syndrome (disorder) |
| Systemic vascular resistance |
Systemic vascular resistance (observable entity) |
| Systemic vascular resistance |
Systemic vascular resistance (observable entity) |
| Systemic vascular resistance |
Systemic vascular resistance (observable entity) |
| Systemic vascular resistance |
Systemic vascular resistance (observable entity) |
| T-formad acetabulumfraktur |
T-shaped fracture |
| T-zone lymphoma |
Peripheral T-cell lymphoma |
| Tacrolimus 0.03% ointment |
Product containing precisely tacrolimus 300 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
| Tacrolimus 0.1% ointment |
Product containing precisely tacrolimus 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
FHIR